FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

2.

Why are so many young adults getting cancer?

3.

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

4.

Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.

5.

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot